- Home
- LRE vs GNTA Comparison
LRE vs GNTA Comparison
Compare LRE & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRE
- GNTA
- Stock Information
- Founded
- LRE 2001
- GNTA 2014
- Country
- LRE Japan
- GNTA Italy
- Employees
- LRE N/A
- GNTA N/A
- Industry
- LRE
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LRE
- GNTA Health Care
- Exchange
- LRE Nasdaq
- GNTA Nasdaq
- Market Cap
- LRE 24.4M
- GNTA 81.2M
- IPO Year
- LRE 2023
- GNTA 2021
- Fundamental
- Price
- LRE $1.80
- GNTA $3.81
- Analyst Decision
- LRE
- GNTA Strong Buy
- Analyst Count
- LRE 0
- GNTA 1
- Target Price
- LRE N/A
- GNTA $25.00
- AVG Volume (30 Days)
- LRE 9.3K
- GNTA 29.8K
- Earning Date
- LRE 01-01-0001
- GNTA 01-01-0001
- Dividend Yield
- LRE N/A
- GNTA N/A
- EPS Growth
- LRE N/A
- GNTA N/A
- EPS
- LRE N/A
- GNTA N/A
- Revenue
- LRE $110,330,328.00
- GNTA N/A
- Revenue This Year
- LRE N/A
- GNTA N/A
- Revenue Next Year
- LRE N/A
- GNTA N/A
- P/E Ratio
- LRE N/A
- GNTA N/A
- Revenue Growth
- LRE 3.92
- GNTA N/A
- 52 Week Low
- LRE $1.10
- GNTA $2.74
- 52 Week High
- LRE $2.49
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- LRE 57.95
- GNTA 52.11
- Support Level
- LRE $1.72
- GNTA $3.53
- Resistance Level
- LRE $1.78
- GNTA $4.00
- Average True Range (ATR)
- LRE 0.08
- GNTA 0.32
- MACD
- LRE -0.01
- GNTA 0.07
- Stochastic Oscillator
- LRE 36.73
- GNTA 84.72
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.